[Myocardial Infarction in the population aged 25-74 in Navarra. Incidence, lethality and treatment in the period 1997-98. IBERICA study].

The principal aim of this study was to determine the incidence of Myocardial Infarction in the population aged 25-74 in Navarra, lethality after 28 days, and the characteristics of the treatment applied in the hospitals during the years 1997-1998. A search was conducted for possible cases of heart attack in the hospital services responsible for attending to them, by means of a review of clinical histories. The lethal cases that did not reach the hospitals were researched through the statistical bulletins of deaths, with the information on these deaths completed through the family doctors. 1,059 coronary events were registered, which corresponded to a crude rate of attack of 238 cases per 100,000 amongst men and 59 cases per 100,000 amongst women. Amongst the male patients who reached hospital alive, 50% were smokers, 41% showed hypercholesterolaemia, 35.9% were hypertense and 16% were diabetic. Amongst the women, who showed a higher average age, arterial hypertension was the most frequent risk factor, with 66%. During hospitalisation thrombolysis was carried out on 39.2% of the patients, primary or rescue angioplasty on 4.6%; aspirin or other anticoagulants were administered to 94.2%, beta-blockers to 60.6% and IECA to 37.4%. This study has shown that the frequency of Myocardial Infarction in Navarra is lower than that registered in many European and North American countries, and is concordant with the low rates of mortality due to this cause. Global analysis of the data shows that a high implementation of the care guidelines for this disease with respect to the use of efficient therapies could be observed in the years 1997 and 1998. Nonetheless, with the exception of the use of anticoagulants, hospital variability has been observed in the use of thrombolytic therapy and adjuvant therapies such as the beta-blockers or ACE Inhibitor, and in the use of diagnostic techniques such as arteriography.

[1]  A. Llácer,et al.  Mortalidad en España en 1998. Evolución en la década 1989-1998. II. Mortalidad general, principales causas de muerte por sexo y edad , 2002 .

[2]  J. García,et al.  Variabilidad en el manejo hospitalario del infarto agudo de miocardio en España. Estudio IBERICA (Investigación, Búsqueda Específica y Registro de Isquemia Coronaria Aguda)* , 2001 .

[3]  R. Moreno Manejo del infarto agudo de miocardio en España. Diferencias interregionales en la actualidad según el registro IBERICA , 2001 .

[4]  F. Arós,et al.  Manejo del infarto de miocardio en España (1995-99). Datos del registro de infartos de la Sección de Cardiopatía Isquémica y Unidades Coronarias (RISCI) de la Sociedad Española de Cardiología , 2001 .

[5]  W. Rogers,et al.  Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. , 2000, Journal of the American College of Cardiology.

[6]  F. Arós,et al.  VARIABILIDAD EN EL MANEJO Y PRONOSTICO A CORTO Y MEDIO PLAZO DEL INFARTO DE MIOCARDIO EN ESPANA : EL ESTUDIO PRIAMHO , 1999 .

[7]  R. Schiele,et al.  [Acute myocardial infarction in Germany between 1996 and 1998: therapy and intrahospital course. Results of the Myocardial Infarction Registry (MIR) in Germany]. , 1999, Zeitschrift fur Kardiologie.

[8]  H. Tunstall-Pedoe,et al.  Contribution of trends in survival and coronar y-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations , 1999, The Lancet.

[9]  Harlan M. Krumholz,et al.  Do “America's Best Hospitals” Perform Better for Acute Myocardial Infarction? , 1999 .

[10]  A. Cabadés,et al.  CARACTERISTICAS, MANEJO Y PRONOSTICO DEL PACIENTE CON INFARTO AGUDO DE MIOCARDIO EN LA COMUNIDAD VALENCIANA EN 1995 : RESULTADOS DEL REGISTRO PRIMVAC (PROYECTO DE REGISTRO DE INFARTO AGUDO DE MIOCARDIO DE VALENCIA, ALICANTE Y CASTELLON) , 1999 .

[11]  H. Tunstall-Pedoe,et al.  Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. , 1999, Lancet.

[12]  G Barbash,et al.  Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial , 1999, The Lancet.

[13]  J. Marrugat,et al.  Acute myocardial infarction case fatality, incidence and mortality rates in a population registry in Gerona, Spain, 1990–1992 , 1998 .

[14]  J. Ferrières,et al.  Management of acute myocardial infarction in intensive care units in 1995: a nationwide French survey of practice and early hospital results. , 1997, Journal of the American College of Cardiology.

[15]  J. Lupón,et al.  Six-month outcome in patients with myocardial infarction initially admitted to tertiary and nontertiary hospitals. RESCATE Investigators. Recursos Empleados en el Síndrome Coronario Agudo y Tiempos de Espera. , 1997, Journal of the American College of Cardiology.

[16]  D Kromhout,et al.  Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe , 1997 .

[17]  M A Hlatky,et al.  Variation among hospitals in coronary-angiography practices and outcomes after myocardial infarction in a large health maintenance organization. , 1996, The New England journal of medicine.

[18]  C. Albert,et al.  Adjunctive drug therapy of acute myocardial infarction--evidence from clinical trials. , 1996, The New England journal of medicine.

[19]  M. R. Ramos,et al.  [Trends in mortality from cardiovascular diseases in Andalucia: 1975-1992]. , 1996 .

[20]  E. Aliot,et al.  A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. , 1995, The New England journal of medicine.

[21]  B. McNeil,et al.  Variation in the use of cardiac procedures after acute myocardial infarction. , 1995, The New England journal of medicine.

[22]  B. Magnani,et al.  The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction , 1995 .

[23]  R. M. Rubison,et al.  Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. , 1994, Circulation.

[24]  M. Rué,et al.  [Tendencies of mortality from cardiovascular diseases in Catalonia: 1975-1992]. , 1993, Medicina clinica.

[25]  G. Lamas,et al.  A comparison of management patterns after acute myocardial infarction in Canada and the United States. The SAVE investigators. , 1993, The New England journal of medicine.

[26]  J. O. Carnicer,et al.  FIBRINOLISIS PREHOSPITALARIA EN EL INFARTO AGUDO DE MIOCARDIO , 1991 .

[27]  F. Rodríguez Artalejo,et al.  Recent coronary heart disease mortality trends in Spain. , 1990, International journal of epidemiology.